![Lon Cardon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lon Cardon
Direktor/Vorstandsmitglied bei
MIRUM PHARMACEUTICALS, INC.
Vermögen: 982 520 $ am 31.05.2026
Profil
Gegenwärtig hat Lon Cardon die Position des Chief Scientific Strategy Officer & Senior VP bei BioMarin Pharmaceutical, Inc. inne. Dr. Cardon ist auch im Vorstand von Reneo Pharmaceuticals, Inc. und Senior Vice President-Target Sciences bei GlaxoSmithKline Plc, Professor an der University of Washington, Professor an der University of Oxford und Professor am Fred Hutchinson Cancer Research Center. Er erhielt einen Doktortitel von der University of Colorado.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 9 680 ( 0,02 % ) | 982 520 $ | 31.05.2026 |
Aktive Positionen von Lon Cardon
| Unternehmen | Position | Beginn |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 19.12.2022 |
The Jackson Laboratory
 The Jackson Laboratory BiotechnologyHealth Technology Operates as a nonprofit biomedical research institution | Vorstandsvorsitzender | 29.11.2021 |
Ehemalige bekannte Positionen von Lon Cardon
| Unternehmen | Position | Ende |
|---|---|---|
| ONKURE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.06.2022 |
| BIOMARIN PHARMACEUTICAL INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2021 |
| GSK PLC | Corporate Officer/Principal | 01.09.2017 |
Open Targets
 Open Targets Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Gründer | - |
Altius Institute For Biomedical Sciences
 Altius Institute For Biomedical Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit research organization for the discovery of biomedicine | Gründer | - |
Ausbildung von Lon Cardon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Puget Sound
 University of Puget Sound Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Jackson Laboratory
The Jackson Laboratory BiotechnologyHealth Technology Operates as a nonprofit biomedical research institution | Health Technology |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Commercial Services |
National Human Genome Research Institute
 National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research | Government |
Reneo Pharmaceuticals, Inc.
 Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Open Targets
Open Targets Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Altius Institute For Biomedical Sciences
Altius Institute For Biomedical Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit research organization for the discovery of biomedicine | Commercial Services |
